Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	HIV-infected 3-day AL	39
Overall Study	STARTED	HIV-infected 5-day AL	37
Overall Study	STARTED	HIV-uninfected 3-day AL	115
Overall Study	STARTED	HIV-uninfected 5-day AL	114
Overall Study	COMPLETED	HIV-infected 3-day AL	35
Overall Study	COMPLETED	HIV-infected 5-day AL	36
Overall Study	COMPLETED	HIV-uninfected 3-day AL	110
Overall Study	COMPLETED	HIV-uninfected 5-day AL	110
Overall Study	NOT COMPLETED	HIV-infected 3-day AL	4
Overall Study	NOT COMPLETED	HIV-infected 5-day AL	1
Overall Study	NOT COMPLETED	HIV-uninfected 3-day AL	5
Overall Study	NOT COMPLETED	HIV-uninfected 5-day AL	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03453840/flow